Capital-Force ETF Trust - CapForce IBD 50 ETF
US ˙ ARCA

SecurityFFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF
InstitutionUBS Group AG
Latest Disclosed Ownership3,214 shares
Latest Disclosed Value $ 107,380
UBS Group AG ownership in FFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 3,214 shares of Capital-Force ETF Trust - CapForce IBD 50 ETF (US:FFTY) valued at $107,380 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 13,570 shares of Capital-Force ETF Trust - CapForce IBD 50 ETF. This represents a change in shares of -76.32% during the quarter. The current value of the position is $135,920 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (FFTY) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 3,214 -10,356 -76.32 107 -77.33 0.0000
2026-01-29 2025-12-31 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 13,570 10,056 286.17 472 260.31 0.0000
2025-11-13 2025-09-30 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 3,514 2,767 370.41 131 445.83 0.0000
2025-08-14 2025-06-30 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 747 0 0.00 24 20.00 0.0000
2025-05-13 2025-03-31 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 747 -1,290 -63.33 20 -65.52 0.0000
2025-02-14 2024-12-31 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 2,037 -1,124 -35.56 58 -31.76 0.0000
2024-11-14 2024-09-30 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 3,161 -1,792 -36.18 85 -37.96 0.0000
2024-08-14 2024-06-30 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 4,953 -632 -11.32 138 -11.04 0.0000
2024-05-13 2024-03-31 13F INNOVATOR ETFS TRUST IBD 50 ETF 45782C102 5,585 213 3.97 154 18.46 0.0000
2024-02-09 2023-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 5,372 -1,817 -25.27 131 -18.75 0.0000
2023-11-09 2023-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 7,189 -3,200 -30.80 161 -39.62 0.0001
2023-08-11 2023-06-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 10,389 -5,749 -35.62 266 -30.45 0.0001
2023-05-12 2023-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 16,138 -1,017 -5.93 382 1.87 0.0001
2023-02-08 2022-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 17,155 -1,424 -7.66 374 -17.62 0.0001
2022-11-10 2022-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 18,579 -7,378 -28.42 454 -34.86 0.0002
2022-08-10 2022-06-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 25,957 -10,604 -29.00 697 -51.22 0.0003
2022-05-16 2022-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 36,561 2,328 6.80 1,429 -8.92 0.0005
2022-02-14 2021-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 34,233 1,366 4.16 1,569 0.77 0.0004
2021-11-15 2021-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 32,867 1,166 3.68 1,557 5.99 0.0005
2021-08-13 2021-06-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 31,701 -12,667 -28.55 1,469 -24.55 0.0005
2021-05-12 2021-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 44,368 9,606 27.63 1,947 36.44 0.0006
2021-02-11 2020-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 34,762 -2,454 -6.59 1,427 2.81 0.0005
2020-11-12 2020-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 37,216 -32,118 -46.32 1,388 -41.85 0.0005
2020-07-31 2020-06-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 69,334 -16,110 -18.85 2,387 -0.21 0.0010
2020-05-01 2020-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 85,444 -123,366 -59.08 2,392 -67.02 0.0011
2020-02-14 2019-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 208,810 -54,133 -20.59 7,252 -14.53 0.0025
2019-11-14 2019-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 262,943 46,573 21.52 8,485 14.37 0.0033
2019-08-14 2019-06-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 216,370 -19,260 -8.17 7,419 -6.06 0.0029
2019-05-14 2019-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 235,630 -60,299 -20.38 7,898 -3.36 0.0033
2019-02-14 2018-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 295,929 -278,967 -48.52 8,173 -63.02 0.0037
2018-11-14 2018-09-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 574,896 73,403 14.64 22,099 25.54 0.0088
2018-08-14 2018-06-30 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 501,493 258,122 106.06 17,603 117.08 0.0076
2018-05-15 2018-03-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 243,371 -58,340 -19.34 8,109 -19.00 0.0035
2018-02-14 2017-12-31 13F INNOVATOR ETFS TR IBD 50 ETF 45782C102 301,711 301,711 10,011 0.0041
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-07-31 2020-06-30 13F INNOVATOR ETFS TR IBD 50 ETF Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F INNOVATOR ETFS TR IBD 50 ETF Put 19,800 1.02 554 -18.65 n/a n/a n/a
2020-02-14 2019-12-31 13F INNOVATOR ETFS TR IBD 50 ETF Put 19,600 681 n/a n/a n/a
2018-11-14 2018-09-30 13F INNOVATOR ETFS TR IBD 50 ETF Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F INNOVATOR ETFS TR IBD 50 ETF Put 100 0.00 4 33.33 n/a n/a n/a
2018-05-15 2018-03-31 13F INNOVATOR ETFS TR IBD 50 ETF Put 100 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.